Indian Covaxin To Boost Mexico's Fight Against Covid-19, Gets Emergency Use Approval From Mexican Drug Regulator
Indian Covaxin To Boost Mexico's Fight Against Covid-19, Gets Emergency Use Approval From Mexican Drug RegulatorBharat Biotech’s COVAXIN, India’s first indigenous vaccine against coronavirus. (Swarajya Magazine)

In a big boost for India's first indigenous Covaxin Covid-19 vaccine, the drug regulator of Mexico has approved the emergency use of the vaccine in the Latin American country.

The Covaxin has been developed by Hyderabad-based Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), and is one of the two vaccines currently being employed in India's Covid-19 vaccination drive. The other Covid-19 vaccine that is being used in India is Serum Institute of India's Covishield.

The Mexican drug regulator, COFEPRIS, has authorized the emergency use of Covaxin, Mexican Foreign Minister Marcelo Ebrard said on Tuesday (7 April).

"Very timely decision by COFEPRIS to authorize the emergency use of COVAXINE vaccine manufactured in India. The options for vaccination against COVID-19 in Mexico are expaning !!!" Ebrard tweeted.

Bharat Biotech's Covaxin is the sixth Covid-19 vaccine that has been greenlighted for emergency use in Mexico. The other firms that got approval for their Covid-19 vaccines in Mexico are AstraZeneca, Cansino, Pfizer, Sinovac and Sputnik V.

An Appeal...

Dear Reader,

As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.

Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.

We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.

Becoming a Patron or a subscriber for as little as Rs 1200/year is the best way you can support our efforts.

Become A Patron
Become A Subscriber